**Core Concept**
A1 antitrypsin deficiency is a genetic disorder characterized by the deficiency of alpha-1 antitrypsin (A1AT), a serine protease inhibitor produced in the liver that protects the lungs from the enzyme neutrophil elastase. This deficiency can lead to lung damage and emphysema, as well as liver disease.

**Why the Correct Answer is Right**
A1AT deficiency is caused by mutations in the SERPINA1 gene, leading to the production of abnormal A1AT protein that accumulates in the liver and lungs. The defective protein is unable to effectively inhibit neutrophil elastase, resulting in excessive elastase activity and tissue damage. This can lead to the development of pulmonary emphysema, particularly in smokers, as well as liver disease and cirrhosis.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as alpha-1 antitrypsin deficiency is not typically associated with cystic fibrosis, although both conditions can cause respiratory disease.
**Option B:** This option is incorrect as Wilson's disease is a genetic disorder affecting copper metabolism, not A1AT.
**Option C:** This option is incorrect as alpha-1 antitrypsin deficiency is not typically associated with hemochromatosis, a genetic disorder affecting iron metabolism.
**Option D:** This option is incorrect as Gaucher's disease is a genetic disorder affecting lysosomal enzyme function, not A1AT.

**Clinical Pearl / High-Yield Fact**
A1AT deficiency is often asymptomatic until adulthood, but can be diagnosed by measuring serum A1AT levels or by genetic testing. It is essential to consider A1AT deficiency in patients with unexplained emphysema or liver disease, particularly those with a family history of the condition.

**Correct Answer: D. Gaucher's disease**